Future Initiatives

Join our initiatives to help the world live in optimal health.

University Initiative

ILSC’s activities are focused on non-communicable diseases (NCD) by advancing the United Nations Agenda 2030 and Sustainable Development Goals, in particular, SDG #3 “Good Health and Well-being”. With this University program, ILSC is reaching out to students of prestigious business schools and challenging them to find business concepts to eventually achieve a world free of underfunded NCDs. During 2021, teams from different universities will compete for solutions and ultimately have the chance to present their ideas to a panel of international experts during a symposium, planned to be held at the United Nations in New York City. The best-judged ideas will also be submitted to media outlets and presented to foundations and entrepreneurs for potential funding.

Four main goals

  • Stimulate an innovative pipeline of business concepts by interested students regarding underfunded non-communicable diseases
  • Build international cohort partnerships between global universities
  • Engage interested stakeholders in relevant disciplines within the UN/NGO community
  • Participation in this program is also a deep learning experience in social entrepreneurship.

Solving goals for real-world problems is a test of each team’s creativity, innovation, and understanding of the interrelationship of global challenges. These students, tomorrow’s leaders, will be active participants in meeting the 2030 objectives of UN SDGs.

Preeclampsia Initiative

Manifesting in up to 10% of pregnancies worldwide, Preeclampsia can cause hypertension, damage to organs including kidneys and even death to the women.

Preeclampsia is difficult to diagnose as the symptoms are similar to many other conditions, sometimes the only cause of action is a premature birth which in itself is very risky to mother and child.

Road to Action

Preeclampsia can be a devastating condition for women in less developed health care systems, in fact it is seven times more prevalent in countries with limited prenatal care. Using the same urinary dipstick that is used for the Sickle Cell Disease Initiative, ILSC, together with prestigious academic research institutions in the United States and Africa,will conduct a limited proof-of-concept trial in sub-Sahara countries in 2021. Our goal is to expand this limited trial into further research. The ultimate hope is that our research could detect early onset of kidney damage due to preeclampsia, allowing early therapeutic interventions and hopefully prolonging lives.